CH LAB-Order (R4)
2.0.0 - trial-use
CH LAB-Order (R4)
2.0.0 - trial-use
This page is part of the CH LAB-Order (R4) (v2.0.0: STU 2) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Mrs Birgit Blum had an unfortunate fall while skiing and sustained a multifragmentary tibial plateau fracture. She was transferred to the Kantonsspital, a centre hospital, by helicopter and is waiting there for her operation. The patient is administered Liquemin 5000 E s.c. daily to prevent thromboembolic events. To monitor the effect of this treatment, regular blood tests are carried out to determine anti-Xa activity. A special sample vessel with citrate additive is used for this purpose. The sample must be centrifuged and cooled within one hour. An important entry from her list of problems is heart disease.
Order Document with Service Request
The patient Tobias Timmermann presents to Dr. Marc Mustermann in the Olten group practice. He identifies himself verbally via his master data as Tobias Timmermann, born on 01.01.1984. He reports unclear leg pain in the left lower leg as well as respiratory pain and coughing occurring at the same time. The doctor takes a medical history and performs a physical examination and orders the following laboratory parameters:
The doctor carries out the Blood count and the CRP determination himself by means of point of care diagnostics, the D-dimer diagnostics is prescribed as quantitative diagnostics in an external sending laboratory. To obtain the sample, a Blood sample is taken lying down (1 EDTA tube, 2 citrate tubes of 5 ml). The order is transmitted to the external laboratory and the sample is sent to the external dispatch laboratory by courier ordered by telephone. The results of the internal point of care diagnostics (Blood count and CRP) are entered in the patient`s laboratory sheet in the doctor`s office software (manually or via locally installed electronic interfaces). A prescription is therefore issued by the doctor to the patient for self-administration of an anti-thrombotic agent. The results of the sending-in laboratory arrive electronically at the GP`s on the same evening and are also entered in the patient`s laboratory sheet. By using the present exchange format, this process can be fully automated. After a telephone enquiry by the doctor at the sending laboratory due to a borderline D-dimer result, the information is given that a deep vein thrombosis cannot be ruled out in this situation by means of D-dimer and the patient is therefore called back the next day for a sonography of the legs. As it is probably a primary leg vein thrombosis, Dr Eva Erlenmeier from the Pipette laboratory sends feedback to Dr Mustermann with the recommendation to carry out a thrombophilia screening, which includes the following analyses: Quick, aPTT, fibrinogen, antithrombin (funct.), thrombin time I 2.5 NIH/ml, APC resistance, D-dimers, protein C, (aPTT method), protein S antigen. The analyses can be carried out directly from the samples of the citrate tubes sent along.
Order Document with ServiceRequest
Order Document with ServiceRequest and Form
A mother visits the family doctor Peter Presto of the Olten group practice with her 6-year-old son Emil Kummer, born 5 May 2014, because the child has been coughing increasingly for a fortnight, with cramping cough attacks, and has a fever. The doctor`s receptionist measures the fever, takes a fingertip Blood sample from the son, determines the CRP and prepares a Blood smear. The doctor suspects a viral infection, but wants to rule out whooping cough, although the child has been vaccinated against it. As he is under time pressure due to an emergency, he does not want to do the necessary throat swab himself, but asks the mother to accompany the child to the nearby laboratory to have the swab done in peace. He prepares a laboratory order to carry out a pertussis PCR on the child`s throat swab and gives the order to the mother. The mother herself is not sure whether she herself has been vaccinated against pertussis. Consequently, the family doctor Peter Presto gives her the pertussis vaccination right away and recommends that the same be done for the child`s father and grandparents. In the meantime, the MPA has looked at the son`s Blood smear under the microscope and finds a lot of reactive lymphocytes, which seem suspicious to her. She is unsure and asks the doctor, who gives the order to give the child`s Blood smears to the mother and also to have them examined more closely in the laboratory. The mother arrives at the laboratory with her son, where the doctor`s order is first to establish the son`s identity. Then a pharyngeal swab and a right cubital venepuncture are taken from the child in the laboratory`s Blood collection room and passed on to the laboratory together with the Blood smears and the doctor`s examination order.
Order Document with ServiceRequest
Order Document with ServiceRequest and Form
The assistant doctor in the gynaecology department at the Olten group practice, Dr. Peter Pap, prepares for the next day’s consultation. As the practice only has a minimal in-house laboratory, some patients are sent to the nearby Pipette laboratory outpatient clinic before the appointment, including the young patient Ms. Marina Rubella, born on 8 August 1992. In her practice software, the MPA prescribes the standard analyses agreed with the laboratory for the gynaecological 3-year examination of patient Rubella. This also includes the blood serum collection for possible follow-up prescriptions. The laboratory will send the results to the practice no later than 90 minutes after the blood sample has been taken. Dr. Pap prescribes the following tests during the consultation:
Order Document with ServiceRequest
Order Document with ServiceRequest and Form
The patient Sara Speckmann, born 12. 12. 1975, has been in the Cantonal Hospital for some time. Last night her general condition deteriorated massively. As there is a suspicion of sepsis, the senior physician in charge, Dr Hans Hauser, orders Blood to be taken from her in the morning for a Blood culture. 30 minutes later, another aerobic and an anaerobic Blood culture is taken, as well as a urine sample. All five samples are further processed in the external laboratory Pipette. There, germs are detected in all materials and then identified by mass spectrometry. The pathogens “Klebsiella pneumoniae” and “Escherichia coli” were detected in the four Blood culture bottles, and the bacterium “Streptococcus mitis” was also detected in one aerobic bottle. The germ identified in the urine sample is normally not pathogenic. An antibiogram is made of all three pathogens detected in the Blood. This shows that the two active substances “amoxicillin+clavulanic acid” and “ceftriaxone” are effective against all three germs. The microbiologist regularly informs Dr Hans Hauser about the various partial results.
Order Document with ServiceRequest
Order Document with ServiceRequest and Form
Companies that work with substances hazardous to health and in which employees are exposed to special risks are subject to occupational health screening by SUVA. Biological monitoring is one of the control options. This assesses the exposure of workers to chemical agents by determining the agents or metabolites in biological material (e.g. urine). The Occupational Medical Prevention (AMV) of SUVA sends the laboratory a monthly list with the following information per company (collective order):
Order Document with ServiceRequest
Order Document with ServiceRequest and Form
A 45-year-old female patient Simone Studer came for her regular skin check to the Arztpraxis of Dermatologist Armin Ahrens, and this lesion was noted: Junctions nevi consisting of seborrheic area top end and atypical network constructed of many seperate dots, structures , etc , suggesting melanocytic involvement. Excision. Attachement of dermatoscopic images Specimen: 29 x 11 x 5 mm skin ellipse Body Site: